Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.550
-0.100 (-2.15%)
At close: Dec 5, 2025, 4:00 PM EST
4.600
+0.050 (1.10%)
After-hours: Dec 5, 2025, 7:25 PM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $120.59 million as of December 5, 2025. Its market cap has increased by 30.84% in one year.
Market Cap
120.59M
Enterprise Value
105.30M
1-Year Change
30.84%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $120.59M, an increase of 92.91%. That is a compound annual growth rate of 11.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 120.59M | 73.76% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |